fda glp-1 safety alert october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Sends Warning Letters to
Description
Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers.
Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases
Their comprehensive superfood blend is one of the most reliable solutions for filling nutritional gaps and supporting whole-body wellness
From medspas and weight loss clinics to telehealth providers, Austin offers a range of options for those looking to begin Semaglutide or Tirzepatide therapy for sustainable...
